Declaration on Vitamin D in Osteoporosis Management

From the European Summit on the Role of Vitamin D in the Management of Osteoporosis: a MetaForum by Hosking, David J. et al.
From the Editor-in-Chief
On October 2005 a multidisciplinary group of delegates, which
included endocrinologists, geriatricians, rheumatologists, ortho-
pedic surgeons, gynecologists, general physicians, nurses, and
patient group representatives were invited to Dublin, Ireland to
draw a Consensus of the group’s opinions to form a document
that would set out a call for action for professional and patient
organizations.
The seven lectures presented by the Faculty members includ-
ed the impact of osteoporosis, the role of vitamin D both in
physiology and in the prevention of fractures and falls in the
elderly, the widespread prevalence of vitamin D inadequacy,
and the patient and physician knowledge and attitude to vita-
min D supplementation. The speakers were challenged with
numerous questions by the skilled and experienced audience
and a MetaForum newsletter was generated (Table I).
The Declaration document encompassed action points to be
accomplished and measures of success at given times. As
some of the deadlines for reaching the proposed goals are ap-
proaching, it could of use to have a thought on what has been
accomplished, how much needs to be done and the possible
ways to hit the targets.
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Table I - Declaration Summary.
– Vitamin D inadequacy (generally defined as < 30 ng/ml or < 75
nmol/l) is common worldwide.
– Individuals have difficulty getting enough vitamin D.
– Vitamin D is essential for calcium absorption.
– Vitamin D supplementation has been shown to reduce the risk of
fracture and falls and helps to improve muscle function (Fig. 1).
– Vitamin D is an essential part of osteoporosis management.
– The efficacy of prescription treatments for osteoporosis is im-
proved by ensuring that patients get enough vitamin D.
– There is an urgent need for all interested bodies to promote
adequate vitamin D intake in patients with osteoporosis.
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Vitamin D inadequacy has important consequences
Declaration points
1. Vitamin D is essential for calcium absorption and bone
health in men and women. Low levels of vitamin D may
lead to suboptimal calcium absorption, secondary hyper-
parathyroidism with high bone turnover and an increased
risk of fractures, especially among those with osteoporosis
and in older people (≥ 65 yrs).
2. Vitamin D is particularly important for maintaining muscle
function and balance. Vitamin D inadequacy may contribute
to the risk of falls and fractures.
3. Vitamin D inadequacy among older women and men world-
wide is widespread regardless of geographical location or
season.
4. Vitamin D is an essential part of osteoporosis manage-
ment. It helps to maximise the effectiveness of prescribed
medicine in the prevention of fractures.
5. All patient and professional organisations supporting pa-
tients with osteoporosis should provide current information
on the critical role of vitamin D in helping reducing falls and
fracture risk.
6. Primary prevention of osteoporosis starts early in life and
continues throughout life. As well as a balanced diet and
daily weight-bearing exercise, adequate caloric intake, cal-
cium and vitamin D are essential for the prevention of os-
teoporosis.
1
Vitamin D is essential for calcium absorption and bone health in
men and women. Low levels of vitamin D may lead to subopti-
mal calcium absorption, secondary hyperparathyroidism with
high bone turnover and an increased risk of fractures, especially
among those with osteoporosis and in older people (≥ 65 yrs).
• Action point:
Identify the key facts which will help women and men as well
as their physicians to understand the importance of vitamin D
in the management of osteoporosis.
• Measuring success:
In clinical practice, patients with vitamin D inadequacy are so
common that widespread treatment is necessary, but measure-
ment of serum 25(OH)D levels is not. Consistent with Euro-
pean Guidelines, we should aim to at least double the number
of osteoporosis patients getting an adequate intake of vitamin
D on a regular basis.
2
Vitamin D is particularly important for maintaining muscle func-
tion and balance. Vitamin D inadequacy may contribute to the
risk of falls and fractures.
• Action point:
In falls management, incorporate advice on avoiding vitamin D
inadequacy.
• Measuring success:
Agreement by falls services to routinely correct vitamin D inad-
equacy.
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Vitamin D status and calcium economy
Current recommendations for vitamin D intake
United States
The IOM has defined adequate daily intake of vitamin D 
according to age:
• Adults up to age 50: 200 IU0 (5 µg)
• Adults 51-70: 400 IU (10 µg)
• Adults > 70: 600 IU (15 µg)
Europe
The Scientific Committee for Food of the Commission of the
European Communities recommends
• 400 IU (10 µg) of vitamin D daily for the elderly (≥ 65 years of age)
BACKGROUND INTAKE: 5 µg (200 Ul/d)
Maintenance of normal extracellular [Ca++] depends on the integrated coor-
dination of extracellular Ca++ flux by intestinal tract, kidney, and bone.
Changes in extracellular Ca++ are mainly regulated by PTH and 1.25(0H)D.
Meta-analysis of vitamin D and falls
Vitamin D and muscle strength
• Low vitamin D levels and reversible myopathy in patients
with osteomalacia and uremia
• Vitamin D receptors in skeletal muscle
• Vitamin D deficiency causes selective atrophy of the rapidly
reacting (type II) fibers
• Increased number and cross sectional area of fast-twitch
muscle fibers after vitamin D treatment
• Vitamin D plus calcium reduce the risk of falling by 49%
compared to calcium alone in the elderly
Adapted from Pent Dial Int. 16:S305, 1996; J Biol Chem. 260:8882,
1985; J Bone Miner Res. 18:343, 2003; Lancet. 2:626, 1976; Clin Sci.
56:157, 1979; Aging 12:455, 2000 
Bischoff-Ferrari HA, JAMA 2004;291:1999-2006
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3Vitamin D inadequacy among older women and men worldwide
is widespread regardless of geographical location or season.
• Action point:
Raise physician awareness of the high prevalence of vitamin D
inadequacy and the need to ensure that it is corrected.
• The key points are:
– very high prevalence of vitamin D inadequacy everywhere;
– there are multiple benefits from vitamin D on muscle function,
falls and bone health;
– vitamin D has a good safety profile, even in higher doses.
• Measuring success:
In patients with osteoporosis, at least double the percentage
who take witamin D by end 2010.
4
Vitamin D is an essential part of osteoporosis management. It
helps to maximise the effectiveness of prescribed medicine in
the prevention of fractures.
• Action point:
Identify the key facts which will help women and men and their
physicians to understand the importance of vitamin D in the
management of osteoporosis.
• The key points are:
– vitamin D is essential to help prevent falls and fractures;
– you cannot absorb enough calcium without vitamin D;
– most people don’t get enough vitamin D from food and sun-
light;
– almost everyone should get vitamin D as part of their treat-
ment, alongside an effective prescribed medicine. Vitamin D
has a good safety profile, even in higher doses.
• Measuring success:
Increase in healthcare professional recommendation to include
vitamin D together with osteoporosis therapies with proven
fracture risk reduction efficacy.
5
All patient and professional organisations supporting patients
with osteoporosis should provide current information on the criti-
cal role of vitamin D in helping reducing falls and fracture risk.
• Action point:
Develop educational materials to explain the importance of vit-
amin D as a critical role in muscle function, bone health and
osteoporosis management and encourage sustained compli-
ance with established national guidelines.
Clinical Cases in Mineral and Bone Metabolism 2007; 4(2): 163-166 165
Declaration on Vitamin D in Osteoporosis Management
Proportion of women with mean serum 25(OH)D
Below cut-off points by region
Defining the upper limit of vitamin D intake
Acceptable upper limit 2000 IU/d
No observed adverse effect level
NOAEL
[25(OH)D → 56 ng/ml] 10000 IU/d
Lowest observed adverse effect level
LOAEL
[25(OH)D → 88 ng/ml] 40000 IU/d
Vitamin D intoxication
[25(OH)D → > 240 ng/ml] ?
Adapted from: Am J Nutr. 69:842, 1999; Am J Clin Nutr. 80:1706S, 2004
Adapted from: Lips P et al. JBMR, 2005
%
 W
om
en
Europe Middle Asia Latin Pacific OVERALL
East America Rim
Dose-response curve, summarizing randomized-control
clinical trials of fracture-prevention using vitamin D, 
with or without calcium
Adapted from: J Ster Biochem Mol Biol. 89-90:575, 2004
Proportion of women with witamin D inadequacy 
according to treatment for osteoporosis
Adapted from: Lips P et al. JBMR, 2005
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• Measuring success:
All osteoporosis patient group literature and websites to include
accurate guidance on importance of vitamin D and adequate
calcium absorption by end 2007.
6
Primary prevention of osteoporosis starts early in life and con-
tinues throughout life. As well as a balanced diet and daily
weight-bearing exercise, adequate caloric intake, calcium and
vitamin D are essential for the prevention of osteoporosis.
• Action point:
Include osteoporosis prevention in schools and general health
education programmes.
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